Response to liposomal doxorubicin and clinical outcome of HIV-1-infected patients with Kaposi's sarcoma receiving highly active antiretroviral therapy

  1. Núñez, M.
  2. Saballs, P.
  3. Valencia, M.E.
  4. Santos, J.
  5. Ferrer, E.
  6. Santos, I.
  7. Berrocal, A.
  8. Galindo, M.J.
  9. Podzamczer, D.
  10. González-Lahoz, J.
  11. Sales, P.
  12. Eulalia, M.
  13. Santos, I.
  14. Sanz, J.
  15. Alsina, M.
  16. Taberner, R.
  17. Górgolas, M.
  18. López-Aldeguer, J.
  19. Sirera, G.
  20. Torres, J.
  21. Colmenero, M.
  22. Bàrreiro, P.
  23. Roca, V.
  24. Domingo, J.
  25. Pedreira, J.D.
Revue:
HIV Clinical Trials

ISSN: 1528-4336

Année de publication: 2001

Volumen: 2

Número: 5

Pages: 429-437

Type: Article

DOI: 10.1310/700B-9QT3-HGN9-Q3FQ GOOGLE SCHOLAR

Objectifs de Développement Durable